The Academy of Managed Care Pharmacy (AMCP) Annual Meeting will see thousands of managed care pharmacy, health care industry professionals and other experts descend upon Houston from March 31 through April 3 to share research and insights with their peers. Researchers from Prime Therapeutics (Prime) will present seven research posters and additional education sessions throughout the week. 

Prime’s research on glucagon-like peptide-1 (GLP-1) receptor agonist drug therapies for weight loss takes center stage with four of its posters that further explore its Year-2 adherence/persistence and cost-of-care data.  

Among the highlights at AMCP 2025, Prime’s GLP-1 Journal of Managed Care & Specialty Pharmacy (JMCP) publication, “Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes,” will be recognized with the 2024 JMCP “Article of the Year” Award for Excellence. Authors of the publication will accept the award at a ceremony later this week. 

Subject matter experts from across the organization will present several education sessions on the latest health care trends, emerging treatments and more. Additional information on these sessions can be found on the AMCP agenda. 

A special edition Pharmacy Friends podcast will be recorded live from AMCP. Check back at the Prime newsroom at PrimeTherapeutics.com/Read or on your favorite podcast platform, later this week. But be sure to listen to the most recent episode of Pharmacy Friends to hear from Prime’s researchers about their work, why it matters and how they strive to provide the kind of care they would want for their loved ones. 

For live updates from Houston, follow Prime on LinkedIn.